Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, R.-q.
Right arrow Articles by Rosen, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, R.-q.
Right arrow Articles by Rosen, E. M.
[Cancer Research 61, 8022-8031, November 1, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Altered Gene Expression Pattern in Cultured Human Breast Cancer Cells Treated with Hepatocyte Growth Factor/Scatter Factor in the Setting of DNA Damage1

Ren-qi Yuan, Saijun Fan, Mohan Achary, Donn M. Stewart, Itzhak D. Goldberg and Eliot M. Rosen2

Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York 11040 [R-q. Y., S. F., I. D. G., E. M. R.]; Departments of Radiation Oncology [M. A., E. M. R.] and Developmental and Molecular Biology [E. M. R.], Albert Einstein College of Medicine, Bronx, New York 10461; and Metabolism Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892 [D. M. S.]

The cytokine hepatocyte growth factor/scatter factor (HGF/SF) protects epithelial and cancer cells against DNA-damaging agents via a pathway involving signaling from c-Met -> phosphatidylinositol-3- kinase -> c-Akt. However, the downstream alterations in gene expression resulting from this pathway have not been established. On the basis of cDNA microarray and semiquantitative RT-PCR assays, we found that MDA-MB-453 human breast cancer cells preincubated with HGF/SF and then exposed to Adriamycin (ADR), a DNA topoisomerase II inhibitor, exhibit an altered pattern of gene expression, as compared with cells treated with ADR only. [HGF/SF+ADR]-treated cells showed altered expression of genes involved in the DNA damage response, cell cycle regulation, signal transduction, metabolism, and development. Some of these alterations suggest mechanisms by which HGF/SF may exert its protective activity, e.g., up-regulation of polycystic kidney disease-1 (a survival-promoting component of cadherin-catenin complexes), down-regulation of 51C (an inositol polyphosphate-5-phosphatase), and down-regulation of TOPBP1 (a topoisomerase IIB binding protein). We showed that enforced expression of the cdc42-interacting protein CIP4, a cytoskeleton-associated protein for which expression was decreased in [HGF/SF+ADR]-treated cells, inhibited HGF/SF-mediated protection against ADR. The cDNA microarray approach may open up new avenues for investigation of the DNA damage response and its regulation by HGF/SF.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
Y. Ma, P. Katiyar, L. P. Jones, S. Fan, Y. Zhang, P. A. Furth, and E. M. Rosen
The Breast Cancer Susceptibility Gene BRCA1 Regulates Progesterone Receptor Signaling in Mammary Epithelial Cells
Mol. Endocrinol., January 1, 2006; 20(1): 14 - 34.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. C. Mallory, G. Crudden, A. Oliva, C. Saunders, A. Stromberg, and R. J. Craven
A Novel Group of Genes Regulates Susceptibility to Antineoplastic Drugs in Highly Tumorigenic Breast Cancer Cells
Mol. Pharmacol., December 1, 2005; 68(6): 1747 - 1756.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Jin, J. Yaung, R. Kannan, S. He, S. J. Ryan, and D. R. Hinton
Hepatocyte Growth Factor Protects RPE Cells from Apoptosis Induced by Glutathione Depletion
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4311 - 4319.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Xu, S. Fan, and E. M. Rosen
Regulation of the Estrogen-Inducible Gene Expression Profile by the Breast Cancer Susceptibility Gene BRCA1
Endocrinology, April 1, 2005; 146(4): 2031 - 2047.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Jurvansuu, K. Raj, A. Stasiak, and P. Beard
Viral Transport of DNA Damage That Mimics a Stalled Replication Fork
J. Virol., January 1, 2005; 79(1): 569 - 580.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Bae, S. Fan, Q. Meng, J. K. Rih, H. J. Kim, H. J. Kang, J. Xu, I. D. Goldberg, A. K. Jaiswal, and E. M. Rosen
BRCA1 Induces Antioxidant Gene Expression and Resistance to Oxidative Stress
Cancer Res., November 1, 2004; 64(21): 7893 - 7909.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.